Carregant...
Carregant...

Vés al contingut (premeu Retorn)

Torafic study protocol: torasemide prolonged release versus furosemide heart failure

Autor
Díez, J.; Coca, A.; Eduardo, D.; Anguita, M.; Castro-Beiras, A.; Conthe, P.; Cobo, E.; Fernández, E.
Tipus d'activitat
Article en revista
Revista
Expert review of cardiovascular therapy
Data de publicació
2009
Volum
2009
Pàgina inicial
897
Pàgina final
904
DOI
https://doi.org/10.1586/ERC.09.74 Obrir en finestra nova
Repositori
http://hdl.handle.net/2117/6524 Obrir en finestra nova
Resum
Loop diuretics, such as torasemide and furosemide, are important agents in the treatment of chronic heart failure. Beneficial effects of torasemide immediate-release formulation beyond diuresis have been documented as the ability of this compound to inhibit myocardial synthesis and deposition of collagen type I in patients with chronic heart failure. In addition, torasemide-treated patients, but not furosemide-treated patients, showed decreased serum concentrations of the C-terminal propeptide o...
Citació
Díez, J. [et al.]. Torafic study protocol: torasemide prolonged release versus furosemide heart failure. "Expert review of cardiovascular therapy", 2009, vol. 2009, p. 897-904.
Paraules clau
Chronic heart failure Furosemide Myocardial fibrosis Torasemide Chronic disease Physiopathology Research design Prospective studies
Grup de recerca
GRBIO - Grup de Recerca en Bioestadística i Bioinformàtica

Participants

  • Díez, Javier  (autor)
  • Coca, Antonio  (autor)
  • de Teresa Galván, Eduardo  (autor)
  • Anguita, Manuel  (autor)
  • Castro-Beiras, Alfonso  (autor)
  • Conthe, Pedro  (autor)
  • Cobo Valeri, Erik  (autor)
  • Fernández, Ester  (autor)